Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · IEX Real-Time Price · USD

1.340

+0.010 (0.75%)

At close: Apr 26, 2024, 4:00 PM

1.330

-0.010 (-0.75%)

After-hours: Apr 26, 2024, 5:54 PM EDT

Akebia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Cash & Equivalents	42.93	90.47	149.8	228.7	147.45	104.64	70.16	187.34	49.78	32.78	Upgrade
Short-Term Investments	0	0	0	39.99	0.25	217	247.64	73.01	88.68	76.14	Upgrade
Cash & Cash Equivalents	42.93	90.47	149.8	268.69	147.69	321.64	317.79	260.34	138.45	108.92	Upgrade
Cash Growth	-52.55%	-39.61%	-44.25%	81.92%	-54.08%	1.21%	22.07%	88.04%	27.12%	234.56%	Upgrade
Receivables	39.29	40.28	51.58	26.85	38.86	16.67	34.22	33.82	0	0	Upgrade
Inventory	15.69	21.57	36.63	61.02	116.35	114.25	0	0	0	0	Upgrade
Other Current Assets	20.24	32.86	33.14	14.88	6.63	15.72	6.35	2.16	2.56	1.56	Upgrade
Total Current Assets	118.15	185.18	271.15	371.44	309.53	468.28	358.36	296.32	141.02	110.48	Upgrade
Property, Plant & Equipment	16.05	34.37	40.61	35.5	39.42	8.02	3.62	2.61	0.54	0.21	Upgrade
Goodwill and Intangibles	95.09	131.13	167.17	199.22	346.27	383.21	0	0	0	0	Upgrade
Other Long-Term Assets	12.42	5.37	50.42	37.98	75.99	137.04	2.27	1.28	1.38	0.31	Upgrade
Total Long-Term Assets	123.55	170.87	258.2	272.7	461.67	528.27	5.89	3.9	1.92	0.52	Upgrade
Total Assets	241.7	356.05	529.35	644.14	771.2	996.54	364.25	300.22	142.94	111	Upgrade
Accounts Payable	14.64	18.02	33.59	41.31	39.22	42.8	7	2.04	2.31	2.02	Upgrade
Deferred Revenue	83.39	88.03	42.38	40.56	72.95	112.69	179.62	197.29	0	0	Upgrade
Current Debt	17.5	32	97.54	0	0	15	0	0	0	0	Upgrade
Other Current Liabilities	-15.65	-8.51	87.54	105.28	95.95	95.21	-45.52	-85.06	9.56	4.86	Upgrade
Total Current Liabilities	99.87	129.54	261.05	187.15	208.12	265.69	141.11	114.27	11.87	6.89	Upgrade
Long-Term Debt	26.13	63.04	33.7	121	103.33	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	146.29	158.25	160.59	88.38	64.99	94.92	100.57	117.83	0.07	0.03	Upgrade
Total Long-Term Liabilities	172.42	221.29	194.29	209.38	168.33	94.92	100.57	117.83	0.07	0.03	Upgrade
Total Liabilities	272.29	350.82	455.34	396.52	376.44	360.61	241.67	232.1	11.94	6.92	Upgrade
Total Debt	43.63	95.04	131.25	121	103.33	15	0	0	0	0	Upgrade
Debt Growth	-54.09%	-27.59%	8.47%	17.10%	588.89%	-	-	-	-	-	Upgrade
Retained Earnings	-1,608.95	-1,557.03	-1,462.8	-1,177.51	-794.05	-514.4	-370.81	-297.14	-161.39	-100.67	Upgrade
Comprehensive Income	0.01	0.01	0.01	0.01	0	-0.26	-0.44	-0.04	-0.23	-0.06	Upgrade
Shareholders' Equity	-30.58	5.23	74.01	247.62	394.76	635.93	122.57	68.12	131	104.08	Upgrade
Net Cash / Debt	-0.71	-4.57	18.55	147.69	44.36	306.64	317.79	260.34	138.45	108.92	Upgrade
Net Cash / Debt Growth	-	-	-87.44%	232.93%	-85.53%	-3.51%	22.07%	88.04%	27.12%	234.56%	Upgrade
Net Cash Per Share	-0.00	-0.03	0.11	1.07	0.37	5.28	7.31	6.90	5.23	7.07	Upgrade
Working Capital	18.28	55.65	10.1	184.29	101.42	202.58	217.25	182.05	129.15	103.6	Upgrade
Book Value Per Share	-0.16	0.03	0.45	1.79	3.33	10.96	2.82	1.81	4.95	6.76	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).